QuidelOrtho Corp (QDEL) stock
QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3063% below fair value
$9.87−0.34 (-3.33%)
Close on Nov 17, 2026Market cap $676.84MP/E –Yield –
QuidelOrtho enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
QuidelOrtho's enterprise value was $3.59B on Nov 11, 2026, against $4.42B a year earlier. Over the last 5 years it ranged from $3.14B to $8.53B, with a median of $4.95B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.59B | -20.3% |
| 2025 | Dec 31, 2025 | $4.50B | -16.7% |
| 2024 | Dec 31, 2024 | $5.40B | -26.9% |
| 2023 | Dec 29, 2023 | $7.39B | -10.8% |
| 2022 | Dec 30, 2022 | $8.29B | +53.6% |
| 2021 | Dec 31, 2021 | $5.40B | – |
See a number that looks wrong?